Table of Content

1 Antibody Drugs Market Overview
1.1 Product Overview and Scope of Antibody Drugs
1.2 Antibody Drugs Segment by Type
1.2.1 Global Antibody Drugs Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Monoclonal Antibodies
1.2.3 Antibody-Drug Conjugates
1.2.4 Polyclonal Antibodies
1.3 Antibody Drugs Segment by Application
1.3.1 Antibody Drugs Sales Comparison by Application: (2021-2027)
1.3.2 Central Nervous System (CNS) Disorders
1.3.3 Cancers
1.3.4 Autoimmune Disorders
1.3.5 Cardiovascular Diseases
1.4 Global Antibody Drugs Market Size Estimates and Forecasts
1.4.1 Global Antibody Drugs Revenue 2016-2027
1.4.2 Global Antibody Drugs Sales 2016-2027
1.4.3 Antibody Drugs Market Size by Region: 2016 Versus 2021 Versus 2027

2 Antibody Drugs Market Competition by Manufacturers
2.1 Global Antibody Drugs Sales Market Share by Manufacturers (2016-2021)
2.2 Global Antibody Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Antibody Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Antibody Drugs Manufacturing Sites, Area Served, Product Type
2.5 Antibody Drugs Market Competitive Situation and Trends
2.5.1 Antibody Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Antibody Drugs Players Market Share by Revenue
2.5.3 Global Antibody Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Antibody Drugs Retrospective Market Scenario by Region
3.1 Global Antibody Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Antibody Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Antibody Drugs Market Facts & Figures by Country
3.3.1 North America Antibody Drugs Sales by Country
3.3.2 North America Antibody Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Antibody Drugs Market Facts & Figures by Country
3.4.1 Europe Antibody Drugs Sales by Country
3.4.2 Europe Antibody Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Antibody Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Antibody Drugs Sales by Region
3.5.2 Asia Pacific Antibody Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Antibody Drugs Market Facts & Figures by Country
3.6.1 Latin America Antibody Drugs Sales by Country
3.6.2 Latin America Antibody Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Antibody Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Antibody Drugs Sales by Country
3.7.2 Middle East and Africa Antibody Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Antibody Drugs Historic Market Analysis by Type
4.1 Global Antibody Drugs Sales Market Share by Type (2016-2021)
4.2 Global Antibody Drugs Revenue Market Share by Type (2016-2021)
4.3 Global Antibody Drugs Price by Type (2016-2021)

5 Global Antibody Drugs Historic Market Analysis by Application
5.1 Global Antibody Drugs Sales Market Share by Application (2016-2021)
5.2 Global Antibody Drugs Revenue Market Share by Application (2016-2021)
5.3 Global Antibody Drugs Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Antibody Drugs Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Novartis Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Amgen
6.2.1 Amgen Corporation Information
6.2.2 Amgen Description and Business Overview
6.2.3 Amgen Antibody Drugs Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Amgen Product Portfolio
6.2.5 Amgen Recent Developments/Updates
6.3 Bristol-Myers Squibb
6.3.1 Bristol-Myers Squibb Corporation Information
6.3.2 Bristol-Myers Squibb Description and Business Overview
6.3.3 Bristol-Myers Squibb Antibody Drugs Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Bristol-Myers Squibb Product Portfolio
6.3.5 Bristol-Myers Squibb Recent Developments/Updates
6.4 F. Hoffmann-La Roche
6.4.1 F. Hoffmann-La Roche Corporation Information
6.4.2 F. Hoffmann-La Roche Description and Business Overview
6.4.3 F. Hoffmann-La Roche Antibody Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 F. Hoffmann-La Roche Product Portfolio
6.4.5 F. Hoffmann-La Roche Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Corporation Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Antibody Drugs Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Johnson & Johnson Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 AbbVie
6.6.1 AbbVie Corporation Information
6.6.2 AbbVie Description and Business Overview
6.6.3 AbbVie Antibody Drugs Sales, Revenue and Gross Margin (2016-2021)
6.6.4 AbbVie Product Portfolio
6.6.5 AbbVie Recent Developments/Updates
6.7 Eli Lilly
6.6.1 Eli Lilly Corporation Information
6.6.2 Eli Lilly Description and Business Overview
6.6.3 Eli Lilly Antibody Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Eli Lilly Product Portfolio
6.7.5 Eli Lilly Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Antibody Drugs Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Pfizer Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 Bayer
6.9.1 Bayer Corporation Information
6.9.2 Bayer Description and Business Overview
6.9.3 Bayer Antibody Drugs Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Bayer Product Portfolio
6.9.5 Bayer Recent Developments/Updates
6.10 GlaxoSmithKline
6.10.1 GlaxoSmithKline Corporation Information
6.10.2 GlaxoSmithKline Description and Business Overview
6.10.3 GlaxoSmithKline Antibody Drugs Sales, Revenue and Gross Margin (2016-2021)
6.10.4 GlaxoSmithKline Product Portfolio
6.10.5 GlaxoSmithKline Recent Developments/Updates
6.11 Sanofi
6.11.1 Sanofi Corporation Information
6.11.2 Sanofi Antibody Drugs Description and Business Overview
6.11.3 Sanofi Antibody Drugs Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Sanofi Product Portfolio
6.11.5 Sanofi Recent Developments/Updates

7 Antibody Drugs Manufacturing Cost Analysis
7.1 Antibody Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Antibody Drugs
7.4 Antibody Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Antibody Drugs Distributors List
8.3 Antibody Drugs Customers

9 Antibody Drugs Market Dynamics
9.1 Antibody Drugs Industry Trends
9.2 Antibody Drugs Growth Drivers
9.3 Antibody Drugs Market Challenges
9.4 Antibody Drugs Market Restraints

10 Global Market Forecast
10.1 Antibody Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Antibody Drugs by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Antibody Drugs by Type (2022-2027)
10.2 Antibody Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Antibody Drugs by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Antibody Drugs by Application (2022-2027)
10.3 Antibody Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Antibody Drugs by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Antibody Drugs by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Antibody Drugs Sales (mg) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Antibody Drugs Sales (mg) Comparison by Application (2021-2027)
Table 3. Global Antibody Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Antibody Drugs Covered in This Study
Table 5. Global Antibody Drugs Sales (mg) of Key Manufacturers (2016-2021)
Table 6. Global Antibody Drugs Sales Share by Manufacturers (2016-2021)
Table 7. Global Antibody Drugs Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Antibody Drugs Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Antibody Drugs Average Price (USD/mg) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Antibody Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Antibody Drugs Product Type
Table 12. Global Antibody Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Antibody Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody Drugs as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Antibody Drugs Sales by Region (2016-2021) & (mg)
Table 16. Global Antibody Drugs Sales Market Share by Region (2016-2021)
Table 17. Global Antibody Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Antibody Drugs Sales by Country (2016-2021) & (mg)
Table 19. North America Antibody Drugs Sales Market Share by Country (2016-2021)
Table 20. North America Antibody Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Antibody Drugs Revenue Market Share by Country (2016-2021)
Table 22. Europe Antibody Drugs Sales by Country (2016-2021) & (mg)
Table 23. Europe Antibody Drugs Sales Market Share by Country (2016-2021)
Table 24. Europe Antibody Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Antibody Drugs Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Antibody Drugs Sales by Region (2016-2021) & (mg)
Table 27. Asia Pacific Antibody Drugs Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Antibody Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Antibody Drugs Revenue Market Share by Region (2016-2021)
Table 30. Latin America Antibody Drugs Sales by Country (2016-2021) & (mg)
Table 31. Latin America Antibody Drugs Sales Market Share by Country (2016-2021)
Table 32. Latin America Antibody Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Antibody Drugs Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Antibody Drugs Sales by Country (2016-2021) & (mg)
Table 35. Middle East and Africa Antibody Drugs Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Antibody Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Antibody Drugs Revenue Market Share by Country (2016-2021)
Table 38. Global Antibody Drugs Sales (mg) by Type (2016-2021)
Table 39. Global Antibody Drugs Sales Market Share by Type (2016-2021)
Table 40. Global Antibody Drugs Revenue (Million US$) by Type (2016-2021)
Table 41. Global Antibody Drugs Revenue Share by Type (2016-2021)
Table 42. Global Antibody Drugs Price (USD/mg) by Type (2016-2021)
Table 43. Global Antibody Drugs Sales (mg) by Application (2016-2021)
Table 44. Global Antibody Drugs Sales Market Share by Application (2016-2021)
Table 45. Global Antibody Drugs Revenue (Million US$) by Application (2016-2021)
Table 46. Global Antibody Drugs Revenue Share by Application (2016-2021)
Table 47. Global Antibody Drugs Price (USD/mg) by Application (2016-2021)
Table 48. Novartis Corporation Information
Table 49. Novartis Description and Business Overview
Table 50. Novartis Antibody Drugs Sales (mg), Revenue (Million US$), Price (USD/mg) and Gross Margin (2016-2021)
Table 51. Novartis Antibody Drugs Product
Table 52. Novartis Recent Developments/Updates
Table 53. Amgen Corporation Information
Table 54. Amgen Description and Business Overview
Table 55. Amgen Antibody Drugs Sales (mg), Revenue (Million US$), Price (USD/mg) and Gross Margin (2016-2021)
Table 56. Amgen Antibody Drugs Product
Table 57. Amgen Recent Developments/Updates
Table 58. Bristol-Myers Squibb Corporation Information
Table 59. Bristol-Myers Squibb Description and Business Overview
Table 60. Bristol-Myers Squibb Antibody Drugs Sales (mg), Revenue (Million US$), Price (USD/mg) and Gross Margin (2016-2021)
Table 61. Bristol-Myers Squibb Antibody Drugs Product
Table 62. Bristol-Myers Squibb Recent Developments/Updates
Table 63. F. Hoffmann-La Roche Corporation Information
Table 64. F. Hoffmann-La Roche Description and Business Overview
Table 65. F. Hoffmann-La Roche Antibody Drugs Sales (mg), Revenue (Million US$), Price (USD/mg) and Gross Margin (2016-2021)
Table 66. F. Hoffmann-La Roche Antibody Drugs Product
Table 67. F. Hoffmann-La Roche Recent Developments/Updates
Table 68. Johnson & Johnson Corporation Information
Table 69. Johnson & Johnson Description and Business Overview
Table 70. Johnson & Johnson Antibody Drugs Sales (mg), Revenue (Million US$), Price (USD/mg) and Gross Margin (2016-2021)
Table 71. Johnson & Johnson Antibody Drugs Product
Table 72. Johnson & Johnson Recent Developments/Updates
Table 73. AbbVie Corporation Information
Table 74. AbbVie Description and Business Overview
Table 75. AbbVie Antibody Drugs Sales (mg), Revenue (Million US$), Price (USD/mg) and Gross Margin (2016-2021)
Table 76. AbbVie Antibody Drugs Product
Table 77. AbbVie Recent Developments/Updates
Table 78. Eli Lilly Corporation Information
Table 79. Eli Lilly Description and Business Overview
Table 80. Eli Lilly Antibody Drugs Sales (mg), Revenue (Million US$), Price (USD/mg) and Gross Margin (2016-2021)
Table 81. Eli Lilly Antibody Drugs Product
Table 82. Eli Lilly Recent Developments/Updates
Table 83. Pfizer Corporation Information
Table 84. Pfizer Description and Business Overview
Table 85. Pfizer Antibody Drugs Sales (mg), Revenue (Million US$), Price (USD/mg) and Gross Margin (2016-2021)
Table 86. Pfizer Antibody Drugs Product
Table 87. Pfizer Recent Developments/Updates
Table 88. Bayer Corporation Information
Table 89. Bayer Description and Business Overview
Table 90. Bayer Antibody Drugs Sales (mg), Revenue (Million US$), Price (USD/mg) and Gross Margin (2016-2021)
Table 91. Bayer Antibody Drugs Product
Table 92. Bayer Recent Developments/Updates
Table 93. GlaxoSmithKline Corporation Information
Table 94. GlaxoSmithKline Description and Business Overview
Table 95. GlaxoSmithKline Antibody Drugs Sales (mg), Revenue (Million US$), Price (USD/mg) and Gross Margin (2016-2021)
Table 96. GlaxoSmithKline Antibody Drugs Product
Table 97. GlaxoSmithKline Recent Developments/Updates
Table 98. Sanofi Corporation Information
Table 99. Sanofi Description and Business Overview
Table 100. Sanofi Antibody Drugs Sales (mg), Revenue (Million US$), Price (USD/mg) and Gross Margin (2016-2021)
Table 101. Sanofi Antibody Drugs Product
Table 102. Sanofi Recent Developments/Updates
Table 103. Production Base and Market Concentration Rate of Raw Material
Table 104. Key Suppliers of Raw Materials
Table 105. Antibody Drugs Distributors List
Table 106. Antibody Drugs Customers List
Table 107. Antibody Drugs Market Trends
Table 108. Antibody Drugs Growth Drivers
Table 109. Antibody Drugs Market Restraints
Table 110. Global Antibody Drugs Sales Forecast by Type (2022-2027) & (mg)
Table 111. Global Antibody Drugs Sales Market Share Forecast by Type (2022-2027)
Table 112. Global Antibody Drugs Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 113. Global Antibody Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 114. Global Antibody Drugs Sales Forecast by Application (2022-2027) & (mg)
Table 115. Global Antibody Drugs Sales Market Share Forecast by Application (2022-2027)
Table 116. Global Antibody Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 117. Global Antibody Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 118. Global Antibody Drugs Sales Forecast by Region (2022-2027) & (mg)
Table 119. Global Antibody Drugs Sales Market Share Forecast by Region (2022-2027)
Table 120. Global Antibody Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 121. Global Antibody Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Antibody Drugs
Figure 2. Global Antibody Drugs Market Share by Type in 2020 & 2027
Figure 3. Monoclonal Antibodies Product Picture
Figure 4. Antibody-Drug Conjugates Product Picture
Figure 5. Polyclonal Antibodies Product Picture
Figure 6. Global Antibody Drugs Market Share by Application in 2020 & 2027
Figure 7. Central Nervous System (CNS) Disorders
Figure 8. Cancers
Figure 9. Autoimmune Disorders
Figure 10. Cardiovascular Diseases
Figure 11. Global Antibody Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Antibody Drugs Market Size 2016-2027 (US$ Million)
Figure 13. Global Antibody Drugs Sales 2016-2027 (mg)
Figure 14. Global Antibody Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Antibody Drugs Sales Share by Manufacturers in 2020
Figure 16. Global Antibody Drugs Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Antibody Drugs Players: Market Share by Revenue in 2020
Figure 18. Antibody Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Antibody Drugs Sales Market Share by Region (2016-2021)
Figure 20. Global Antibody Drugs Sales Market Share by Region in 2020
Figure 21. Global Antibody Drugs Revenue Market Share by Region (2016-2021)
Figure 22. Global Antibody Drugs Revenue Market Share by Region in 2020
Figure 23. U.S. Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. U.A.E Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Antibody Drugs by Type (2016-2021)
Figure 48. Sales Market Share of Antibody Drugs by Application (2016-2021)
Figure 49. Sales Market Share of Antibody Drugs by Application in 2020
Figure 50. Revenue Share of Antibody Drugs by Application (2016-2021)
Figure 51. Revenue Share of Antibody Drugs by Application in 2020
Figure 52. Manufacturing Cost Structure of Antibody Drugs
Figure 53. Manufacturing Process Analysis of Antibody Drugs
Figure 54. Antibody Drugs Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed